The Unintended Consequences of Weight-Loss Medication: A Shift in Social Habits?

The recent surge in popularity of weight-loss medication has brought about a curious side effect that is changing relationships with alcohol for many users. Studies have shown that these medications, which contain semaglutide or tirzepatide and mimic the natural hormone GLP-1, suppress appetite and reduce cravings for substances like alcohol and nicotine.

For some users, this has been a welcome bonus in their weight-loss journey. Lisa Rees reported that she had reduced her wine consumption from two bottles to just three glasses over nine hours at a recent festival after taking her first dose of Wegovy. Warren Thomas noticed the effect within 24 hours of his first dose and now finds himself with “no appetite for drinking.”

However, not everyone has been pleased with this unintended consequence. Faye Goodwin, a 20-year-old graduate who takes Mounjaro, feels that it has hampered her social life. She reports getting nauseous quickly when she drinks, which makes it difficult for her to enjoy social events with friends.

The impact of weight-loss medication on relationships with alcohol is not limited to individual experiences. A study published by the University of Colorado Anschutz found that GLP-1 medications in pill form led to fewer days of heavy drinking in people with mild to moderate alcohol use disorder. Another study, conducted externally in 2025 by Dr Christian Hendershot, found that participants with alcohol use disorder craved alcohol less while taking Ozempic.

The National Health Service recommends not drinking more than 14 units a week, but many users are finding themselves naturally reducing their consumption due to the medication’s effects on their bodies. Prof Russell Hearn, a GP and professor of medicine at King’s College London, advises his patients to “drink less” alongside changing their diet while taking GLP-1 medications.

However, there is a risk that this shift in social habits could be misinterpreted as a solution to the problem of excessive drinking. The root causes of alcohol use disorder are complex and multifaceted, and weight-loss medication should not be seen as a silver bullet for addressing these issues.

As more people turn to weight-loss medication, it’s essential to consider the broader implications on our social habits and relationships with alcohol. Will we see a shift towards more moderate drinking cultures, or will the benefits of reduced cravings come at the cost of lost friendships and social connections? The data suggests that observational studies of the general population are needed to fully understand the effects of weight-loss medication on drinking habits.

Healthcare professionals must provide nuanced advice to patients about their relationships with alcohol. While some users may find themselves naturally reducing their consumption, others like Faye Goodwin may need additional support in navigating these changes. By acknowledging both the benefits and limitations of weight-loss medication, we can work towards a more balanced understanding of its impact on our social lives.

The unintended consequences of weight-loss medication serve as a reminder that even well-intentioned interventions can have unforeseen effects on individuals and society at large. As we continue to explore the potential of these medications, it’s essential to stay vigilant about their broader implications and work towards creating a more inclusive and compassionate culture around health, wellness, and relationships with substances like alcohol.